Oncology

Latest News

Radiotherapy can work synergistically with immunotherapy by reprogramming the tumor microenvironment. | Image credit: Crystallight-stock.adobe.com
Brain Radiotherapy Plus ICIs Boost Survival in SCLC With Brain Metastases

July 30th 2025

A retrospective analysis found whole brain radiation therapy alongside immune checkpoint inhibitors led to “brilliant” 2-year overall survival rates.

As SCLC continues to pose a therapeutic challenge due to rapid progression and early metastasis, the convergence of immunotherapy and precision radiation holds promise to extend survival and improve outcomes. | Image credit: mi_viri - stock.adobe.com
Chemoimmunotherapy Shows Promise for Limited-Stage SCLC in Real-World Study

July 29th 2025

The findings suggest that inhibition of midkine might be a meaningful tool to improve treatment outcomes in SCLC. | Image credit: Pixel-Shot - stock.adobe.com
Midkine May Play Key Role in SCLC

July 24th 2025

The FDA has issued a complete response letter for RP1 plus nivolumab for advanced melanoma after a PD-1 inhibitor–containing regimen. | Image credit: ra2studio - stock.adobe.com
RP1 Plus Nivolumab Receives CRL for Advanced Melanoma

July 24th 2025

David Nguyen, MD | Image Credit: Tufts Medicine
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD

July 23rd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
July 31st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 31st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

CDK4/6 Inhibitors in Metastatic Breast Cancer
December 13th 2018

CDK4/6 Inhibitors in Metastatic Breast Cancer

Medically Integrated Pharmacy Teams Spur Innovations
December 13th 2018

Medically Integrated Pharmacy Teams Spur Innovations

Oral Oncolytics and Patient Adherence
December 13th 2018

Oral Oncolytics and Patient Adherence

Medically Integrated Dispensing Service Best Practices
December 13th 2018

Medically Integrated Dispensing Service Best Practices

Practical Challenges in Switching to CDK4/6 Inhibitors
December 13th 2018

Practical Challenges in Switching to CDK4/6 Inhibitors

The Efficacy and Safety of CDK4/6 Inhibitors
December 13th 2018

The Efficacy and Safety of CDK4/6 Inhibitors

Roles of the Oncologist Versus Pharmacist
December 13th 2018

Roles of the Oncologist Versus Pharmacist

Site Logo
December 13th 2018

Multidisciplinary Approach to Managing Oral Oncolytics

The Advent of Oral Oncolytics and Patient Access
December 13th 2018

The Advent of Oral Oncolytics and Patient Access

Site Logo
December 12th 2018

From the Editor-in-Chief: Why the Future Never Arrives

Joseph Alvarnas, MD
Site Logo
December 12th 2018

Biosimilars Updates

Kelly Davio Samantha DiGrande
Site Logo
December 12th 2018

Medical World News: Regulatory Updates

Site Logo
December 12th 2018

Medical World News: Clinical Updates

Site Logo
December 11th 2018

Medical World News: Managed Care Updates, December 11, 2018

Mary Caffrey Allison Inserro Laura Joszt, MA David Bai, PharmD Samantha DiGrande
Site Logo
December 11th 2018

Cost Variation and Savings Opportunities in the Oncology Care Model

James Baumgardner, PhD Ahva Shahabi, PhD Christopher Zacker, RPh, PhD Darius Lakdawalla, PhD
Geographic variation in cancer treatment spending reveals that chemotherapy and hospital inpatient care may offer opportunities for savings for practices participating in the Oncology Care Model.
Site Logo
December 11th 2018

Getting the Patient's Viewpoint in the Oncology Quality Equation

Mary Caffrey
A recap of the discussion at the Philadelphia meeting of the Institute for Value-Based Medicine®, an initiative of The American Journal of Managed Care®.
Site Logo
December 11th 2018

OneOncology to Add Former US Senate Majority Leader Senator Bill Frist to Board of Directors

Former Tennessee US senator, heart and lung transplant surgeon, and healthcare entrepreneur brings dynamic expertise to the OneOncology national network.
Site Logo
December 10th 2018

Data and Collaboration Are Key for Value-Based Care Success

Laura Joszt, MA
Recap of the November 7 meeting of The American Journal of Managed Care®’s The Institute for Value-Based Medicine®. The dinner discussion, “Advancing Quality in Oncology Care” was held in Seattle, Washington.
Site Logo
December 10th 2018

McAneny Discusses OCM, Community Practices, and Building the Right Rewards

Surabhi Dangi-Garimella, PhD
The American Journal of Managed Care® sat down with Barbara McAneny, MD, president of the American Medical Association (AMA), to discuss how the AMA is working to "help create the healthcare system of the future."
Site Logo
December 10th 2018

Cancer Today and Cancer Tomorrow: Analysis of US Cancer Claims, 2007-2017

In this article, we use data from our FAIR Health database of over 27 billion privately billed healthcare claims to identify the cancer diagnosis categories with the highest percentage of claim lines among all cancer diagnosis categories.
Dr Lawrence Shulman Discusses Pathways and Improvements in Breast Cancer Treatment
December 8th 2018

Dr Lawrence Shulman Discusses Pathways and Improvements in Breast Cancer Treatment

Improvements in treatments have led to less toxicities and better quality of life for patients with breast cancer, said Lawrence N. Shulman, MD, director of the Center for Global Cancer Medicine at the Abramson Cancer Center, and professor of Medicine at the Hospital of the University of Pennsylvania.
Site Logo
December 7th 2018

The Future of Cancer Care

Joseph Alvarnas, MD
Joseph Alvarnas, MD, discusses the history of cancer care and what the future might look like in the space.
Site Logo
December 7th 2018

Renting Health vs Buying Cures: How New Financing Tools Can Boost Cancer Therapy Development

Andrew Smith
Evidence-Based OncologyTM sat down with Andrew W. Lo, PhD, to discuss his proposals to increase investment in medical innovation and utilization by giving investors more ways to support both research organizations and individual patients.
Site Logo
December 7th 2018

Increasing Rates of Cancer Screening

John B. Kisiel, MD
John B. Kisiel, MD, and Philip Parks, MD, MPH, provide an update on the future of cancer screenings and explain how improved treatment regimens offer the potential to reduce the cancer-related healthcare cost burden.
Beth Wittmer on Keeping Patients With Neutropenia Out of the Emergency Department
December 7th 2018

Beth Wittmer on Keeping Patients With Neutropenia Out of the Emergency Department

Informing patients about what to look for with neutropenia can help keep them out of the emergency department (ED) so they can be treated in the clinic, instead, said Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Dr Sibel Blau Outlines Changes to Her Practice to Prepare for OCM
December 6th 2018

Dr Sibel Blau Outlines Changes to Her Practice to Prepare for OCM

Years before the Oncology Care Model (OCM) was implemented, Northwest Medical Specialties started preparing by making changes to the personnel in the practice, explained Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Dr Thorvardur Halfdanarson Discusses Lack of Risk Factors, Biomarkers in NETs
December 4th 2018

Dr Thorvardur Halfdanarson Discusses Lack of Risk Factors, Biomarkers in NETs

There is a lot of disagreement, even within the neuroendocrine tumor (NET) circles, that there are biomarkers that predict outcomes and some that may even predict responses to therapy, explained Thorvardur Halfdanarson, MD, associate professor of medicine and consultant in medical oncology, Mayo Clinic.
Site Logo
November 30th 2018

CDC Data: Life Expectancy Decreases as Deaths From Suicide, Drug Overdose Increase

Laura Joszt, MA
New reports from the CDC have highlighted troubling increasing trends in suicides and drug overdose rates as life expectancy in the United States declined.
Cancer Therapy's Impact on Cognitive Function May Be Due to Accelerated Aging
November 28th 2018

Cancer Therapy's Impact on Cognitive Function May Be Due to Accelerated Aging

Kelly Davio
A study published this week suggests that some anticancer treatments speed up the biological aging process, and this aging effect could be linked to the cognitive decline experienced by patients undergoing cancer treatment.
Podcast: This Week in Managed Care—Addressing Social Needs Impacting Health and Other Health News
November 24th 2018

Podcast: This Week in Managed Care—Addressing Social Needs Impacting Health and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
<1
...
353637383940414243
...
187>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo